Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.

Comi G, Alroughani R, Boster AL, Bass AD, Berkovich R, Fernández Ó, Kim HJ, Limmroth V, Lycke J, Macdonell RA, Sharrack B, Singer BA, Vermersch P, Wiendl H, Ziemssen T, Jacobs A, Daizadeh N, Rodriguez CE, Traboulsee A; CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators.

Mult Scler. 2019 Nov 25:1352458519888610. doi: 10.1177/1352458519888610. [Epub ahead of print]

PMID:
31762387
2.

What does 'PEWing' or 'PEWsing' mean? A new word in paediatrics.

Diskin C, MacDonell R, Whelan B, O' Shea O, Fitzsimons JJ, Vaughan D, Coghlan D.

Arch Dis Child. 2019 Nov 20. pii: archdischild-2019-318252. doi: 10.1136/archdischild-2019-318252. [Epub ahead of print] No abstract available.

PMID:
31748221
3.

Site-Selective Isomerization of Cyano-Substituted Butadienes: Chemical Control of Nonadiabatic Dynamics.

MacDonell RJ, Schuurman MS.

J Phys Chem A. 2019 Jun 6;123(22):4693-4701. doi: 10.1021/acs.jpca.9b02446. Epub 2019 May 22.

PMID:
31050897
4.

Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study.

Miller AE, Xu X, Macdonell R, Vucic S, Truffinet P, Benamor M, Thangavelu K, Freedman MS.

J Clin Neurosci. 2019 Jan;59:229-231. doi: 10.1016/j.jocn.2018.09.012. Epub 2018 Oct 20.

5.

Bilateral facial nerve palsies secondary to chronic inflammatory demyelinating polyneuropathy following adalimumab treatment.

Yao A, Chan H, Macdonell RAL, Shuey N, Khong JJ.

Clin Neurol Neurosurg. 2018 Jan;164:64-66. doi: 10.1016/j.clineuro.2017.11.001. Epub 2017 Nov 22.

PMID:
29179036
6.

The professional practice and training of neurology in the Asian and Oceanian Region: A cross-sectional survey by the Asian and Oceanian Association of Neurology (AOAN).

Roxas A Jr, Mehndiratta MM, Bornstein N, Macdonell R, Lim KS, Ng PW, Dashzeveg S, Mizusawa H, Esmatullah H, Wu SL, Chen C, Kurniawan M, Rha JH, Wasay M, Poungvarin N, Gunatilake S, Thang NH.

J Neurol Sci. 2017 Nov 15;382:108-115. doi: 10.1016/j.jns.2017.09.022. Epub 2017 Sep 20.

PMID:
29111001
7.

Incidence and prevalence of NMOSD in Australia and New Zealand.

Bukhari W, Prain KM, Waters P, Woodhall M, O'Gorman CM, Clarke L, Silvestrini RA, Bundell CS, Abernethy D, Bhuta S, Blum S, Boggild M, Boundy K, Brew BJ, Brown M, Brownlee WJ, Butzkueven H, Carroll WM, Chen C, Coulthard A, Dale RC, Das C, Dear K, Fabis-Pedrini MJ, Fulcher D, Gillis D, Hawke S, Heard R, Henderson APD, Heshmat S, Hodgkinson S, Jimenez-Sanchez S, Killpatrick T, King J, Kneebone C, Kornberg AJ, Lechner-Scott J, Lin MW, Lynch C, Macdonell R, Mason DF, McCombe PA, Pender MP, Pereira JA, Pollard JD, Reddel SW, Shaw C, Spies J, Stankovich J, Sutton I, Vucic S, Walsh M, Wong RC, Yiu EM, Barnett MH, Kermode AG, Marriott MP, Parratt JDE, Slee M, Taylor BV, Willoughby E, Wilson RJ, Vincent A, Broadley SA.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):632-638. doi: 10.1136/jnnp-2016-314839. Epub 2017 May 26.

8.

Motor neurone disease: progress and challenges.

Dharmadasa T, Henderson RD, Talman PS, Macdonell RA, Mathers S, Schultz DW, Needham M, Zoing M, Vucic S, Kiernan MC.

Med J Aust. 2017 May 1;206(8):357-362. Review.

PMID:
28446118
9.

Reply: Transcranial magnetic stimulation as a biomarker for epilepsy.

Badawy RA, Macdonell RA, Berkovic SF, Vogrin SJ, Jackson GD, Cook MJ.

Brain. 2017 Mar 1;140(3):e19. doi: 10.1093/brain/aww346. No abstract available.

PMID:
28364546
10.

Paediatric early warning systems for detecting and responding to clinical deterioration in children: a systematic review.

Lambert V, Matthews A, MacDonell R, Fitzsimons J.

BMJ Open. 2017 Mar 13;7(3):e014497. doi: 10.1136/bmjopen-2016-014497. Review.

11.

Protein/amino-acid modulation of bone cell function.

MacDonell R, Hamrick MW, Isales CM.

Bonekey Rep. 2016 Aug 10;5:827. doi: 10.1038/bonekey.2016.58. eCollection 2016. Review.

12.

Acute Flaccid Paralysis: The New, The Old, and The Preventable.

Macesic N, Hall V, Mahony A, Hueston L, Ng G, Macdonell R, Hughes A, Fitt G, Grayson ML.

Open Forum Infect Dis. 2015 Dec 9;3(1):ofv190. doi: 10.1093/ofid/ofv190. eCollection 2016 Jan. Erratum in: Open Forum Infect Dis. 2017 Aug 05;4(3):ofx019.

13.

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.

Macdonell R, Nagels G, Laplaud DA, Pozzilli C, de Jong B, Martins da Silva A, Nicholas R, Lechner-Scott J, Gaebler JA, Agarwal S, Wang P, Yeh M, Hovenden M, Soelberg Sørensen P.

Mult Scler. 2016 Jun;22(7):944-54. doi: 10.1177/1352458515606809. Epub 2015 Oct 7.

PMID:
26447066
14.

Photodissociation dynamics of cyclopropenylidene, c-C3 H2.

Schuurman MS, Giegerich J, Pachner K, Lang D, Kiendl B, MacDonell RJ, Krueger A, Fischer I.

Chemistry. 2015 Oct 5;21(41):14486-95. doi: 10.1002/chem.201501624. Epub 2015 Aug 19.

PMID:
26385048
15.

The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis.

Simpson M, Macdonell R.

Mult Scler Relat Disord. 2015 Sep;4(5):430-436. doi: 10.1016/j.msard.2015.06.014. Epub 2015 Jun 23. Review.

PMID:
26346791
16.

A new era in the treatment of multiple sclerosis.

Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies JM, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E.

Med J Aust. 2015 Aug 3;203(3):139-41, 141e.1. Review.

PMID:
26224184
17.

Randomized comparison trial of density and context of upper limb intensive group versus individualized occupational therapy for children with unilateral cerebral palsy.

Sakzewski L, Miller L, Ziviani J, Abbott DF, Rose S, Macdonell RA, Boyd RN.

Dev Med Child Neurol. 2015 Jun;57(6):539-47. doi: 10.1111/dmcn.12702. Epub 2015 Jan 27.

18.

Evolution, current status, and way forward for the Asian Oceanian Association of Neurology.

Mehndiratta MM, Mehndiratta P, Tsai CP, Kaji R, Gulati NS, Wasay M, Macdonell R.

Neurology. 2014 Nov 11;83(20):1853-5. doi: 10.1212/WNL.0000000000000975. No abstract available.

PMID:
25385828
19.

Fifteen-year global time series of satellite-derived fine particulate matter.

Boys BL, Martin RV, van Donkelaar A, MacDonell RJ, Hsu NC, Cooper MJ, Yantosca RM, Lu Z, Streets DG, Zhang Q, Wang SW.

Environ Sci Technol. 2014 Oct 7;48(19):11109-18. doi: 10.1021/es502113p. Epub 2014 Sep 24.

PMID:
25184953
20.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.

Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies J, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E; MS Neurology Group of the Australian and New Zealand Association of Neurologists.

J Clin Neurosci. 2014 Nov;21(11):1857-65. doi: 10.1016/j.jocn.2014.01.017. Epub 2014 Jun 30. Review.

PMID:
24993136
21.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists.

Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies J, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E; MS Neurology Group of the Australian and New Zealand Association of Neurologists.

J Clin Neurosci. 2014 Nov;21(11):1835-46. doi: 10.1016/j.jocn.2014.01.016. Epub 2014 Jun 30. Review.

PMID:
24993135
22.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.

Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies J, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E; MS Neurology Group of the Australian and New Zealand Association of Neurologists.

J Clin Neurosci. 2014 Nov;21(11):1847-56. doi: 10.1016/j.jocn.2014.01.018. Epub 2014 Jun 28. Review.

PMID:
24986155
23.

Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.

Miller AE, Macdonell R, Comi G, Freedman MS, Kappos L, Mäurer M, Olsson TP, Wolinsky JS, Bozzi S, Dive-Pouletty C, O'Connor PW.

J Neurol. 2014 Sep;261(9):1781-8. doi: 10.1007/s00415-014-7395-7. Epub 2014 Jun 28.

24.

Internal jugular and vertebral vein volume flow in patients with clinically isolated syndrome or mild multiple sclerosis and healthy controls: results from a prospective sonographer-blinded study.

Chambers B, Chambers J, Churilov L, Cameron H, Macdonell R.

Phlebology. 2014 Sep;29(8):528-35. doi: 10.1177/0268355513505505. Epub 2013 Sep 24.

PMID:
24065289
25.

COMBIT: protocol of a randomised comparison trial of COMbined modified constraint induced movement therapy and bimanual intensive training with distributed model of standard upper limb rehabilitation in children with congenital hemiplegia.

Boyd RN, Ziviani J, Sakzewski L, Miller L, Bowden J, Cunnington R, Ware R, Guzzetta A, Al Macdonell R, Jackson GD, Abbott DF, Rose S.

BMC Neurol. 2013 Jun 28;13:68. doi: 10.1186/1471-2377-13-68.

26.

In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.

Takano A, Piehl F, Hillert J, Varrone A, Nag S, Gulyás B, Stenkrona P, Villemagne VL, Rowe CC, Macdonell R, Tawil NA, Kucinski T, Zimmermann T, Schultze-Mosgau M, Thiele A, Hoffmann A, Halldin C.

EJNMMI Res. 2013 Apr 24;3(1):30. doi: 10.1186/2191-219X-3-30.

27.

Cortical excitability and neurology: insights into the pathophysiology.

Badawy RA, Loetscher T, Macdonell RA, Brodtmann A.

Funct Neurol. 2012 Jul-Sep;27(3):131-45. Review.

28.

Cortical excitability and refractory epilepsy: a three-year longitudinal transcranial magnetic stimulation study.

Badawy RA, Jackson GD, Berkovic SF, Macdonell RA.

Int J Neural Syst. 2013 Feb;23(1):1250030. doi: 10.1142/S012906571250030X. Epub 2012 Dec 3.

PMID:
23273126
29.

Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.

Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, Day T, Gates P, Macdonell R, Roberts L, Rodriguez-Casero V, Wijeratne T, Kiers L.

Med J Aust. 2012 Nov 19;197(10):574-8. Erratum in: Med J Aust. 2014 Apr 7;200(6):321. Macdonnell, Richard [corrected to Macdonell, Richard].

PMID:
23163689
30.

Baseline smoking status and the long-term risk of death or nonfatal vascular event in people with stroke: a 10-year survival analysis.

Kim J, Gall SL, Dewey HM, Macdonell RA, Sturm JW, Thrift AG.

Stroke. 2012 Dec;43(12):3173-8. doi: 10.1161/STROKEAHA.112.668905. Epub 2012 Oct 25.

PMID:
23103491
31.

Chronic cerebrospinal venous insufficiency is not more prevalent in patients with mild multiple sclerosis: a sonographer-blinded, case-control ultrasound study.

Chambers B, Chambers J, Cameron H, Macdonell R.

Mult Scler. 2013 May;19(6):749-56. doi: 10.1177/1352458512459986. Epub 2012 Sep 7.

PMID:
22961213
32.

Cortical excitability decreases in Lennox-Gastaut syndrome.

Badawy RA, Macdonell RA, Vogrin SJ, Lai A, Cook MJ.

Epilepsia. 2012 Sep;53(9):1546-53. doi: 10.1111/j.1528-1167.2012.03599.x. Epub 2012 Jul 19.

33.

Subacute combined degeneration of the spinal cord despite prophylactic vitamin B12 treatment.

Tsang BK, Crump N, Macdonell RA.

J Clin Neurosci. 2012 Jun;19(6):908-10. doi: 10.1016/j.jocn.2011.08.028. Epub 2012 Feb 18.

PMID:
22342235
34.

Multiple sclerosis- diagnosis, management and prognosis.

Tsang BK, Macdonell R.

Aust Fam Physician. 2011 Dec;40(12):948-55.

35.

Inter-session repeatability of cortical excitability measurements in patients with epilepsy.

Badawy RA, Jackson GD, Berkovic SF, Macdonell RA.

Epilepsy Res. 2012 Feb;98(2-3):182-6. doi: 10.1016/j.eplepsyres.2011.09.011. Epub 2011 Oct 21.

PMID:
22018906
36.

Factors associated with quality of life in 7-year survivors of stroke.

Leach MJ, Gall SL, Dewey HM, Macdonell RA, Thrift AG.

J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1365-71. doi: 10.1136/jnnp.2010.234765. Epub 2011 May 7.

PMID:
21551472
37.

Participation outcomes in a randomized trial of 2 models of upper-limb rehabilitation for children with congenital hemiplegia.

Sakzewski L, Ziviani J, Abbott DF, Macdonell RA, Jackson GD, Boyd RN.

Arch Phys Med Rehabil. 2011 Apr;92(4):531-9. doi: 10.1016/j.apmr.2010.11.022.

PMID:
21440700
38.

Equivalent retention of gains at 1 year after training with constraint-induced or bimanual therapy in children with unilateral cerebral palsy.

Sakzewski L, Ziviani J, Abbott DF, Macdonell RA, Jackson GD, Boyd RN.

Neurorehabil Neural Repair. 2011 Sep;25(7):664-71. doi: 10.1177/1545968311400093. Epub 2011 Mar 22.

PMID:
21427273
39.

Randomized trial of constraint-induced movement therapy and bimanual training on activity outcomes for children with congenital hemiplegia.

Sakzewski L, Ziviani J, Abbott DF, Macdonell RA, Jackson GD, Boyd RN.

Dev Med Child Neurol. 2011 Apr;53(4):313-20. doi: 10.1111/j.1469-8749.2010.03859.x.

40.

SENSe: Study of the Effectiveness of Neurorehabilitation on Sensation: a randomized controlled trial.

Carey L, Macdonell R, Matyas TA.

Neurorehabil Neural Repair. 2011 May;25(4):304-13. doi: 10.1177/1545968310397705. Epub 2011 Feb 24.

PMID:
21350049
41.

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis.

Devonshire V, Lapierre Y, Macdonell R, Ramo-Tello C, Patti F, Fontoura P, Suchet L, Hyde R, Balla I, Frohman EM, Kieseier BC; GAP Study Group.

Eur J Neurol. 2011 Jan;18(1):69-77. doi: 10.1111/j.1468-1331.2010.03110.x.

PMID:
20561039
42.

Can changes in cortical excitability distinguish progressive from juvenile myoclonic epilepsy?

Badawy RA, Macdonell RA, Jackson GD, Berkovic SF.

Epilepsia. 2010 Oct;51(10):2084-8. doi: 10.1111/j.1528-1167.2010.02557.x.

43.

Predicting seizure control: cortical excitability and antiepileptic medication.

Badawy RA, Macdonell RA, Berkovic SF, Newton MR, Jackson GD.

Ann Neurol. 2010 Jan;67(1):64-73. doi: 10.1002/ana.21806.

PMID:
20186859
44.

Sex differences in presentation, severity, and management of stroke in a population-based study.

Gall SL, Donnan G, Dewey HM, Macdonell R, Sturm J, Gilligan A, Srikanth V, Thrift AG.

Neurology. 2010 Mar 23;74(12):975-81. doi: 10.1212/WNL.0b013e3181d5a48f. Epub 2010 Feb 24.

PMID:
20181922
45.

INCITE: A randomised trial comparing constraint induced movement therapy and bimanual training in children with congenital hemiplegia.

Boyd R, Sakzewski L, Ziviani J, Abbott DF, Badawy R, Gilmore R, Provan K, Tournier JD, Macdonell RA, Jackson GD.

BMC Neurol. 2010 Jan 12;10:4. doi: 10.1186/1471-2377-10-4.

46.

Why do seizures in generalized epilepsy often occur in the morning?

Badawy RA, Macdonell RA, Jackson GD, Berkovic SF.

Neurology. 2009 Jul 21;73(3):218-22. doi: 10.1212/WNL.0b013e3181ae7ca6.

PMID:
19620610
47.

Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.

Cervantes-Castañeda RA, Giuliari GP, Gallagher MJ, Yilmaz T, MacDonell RE, Quinones K, Foster CS.

Eur J Ophthalmol. 2009 Jul-Aug;19(4):622-9.

PMID:
19551679
48.

The peri-ictal state: cortical excitability changes within 24 h of a seizure.

Badawy R, Macdonell R, Jackson G, Berkovic S.

Brain. 2009 Apr;132(Pt 4):1013-21. doi: 10.1093/brain/awp017. Epub 2009 Feb 27.

PMID:
19251759
49.

Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy - part 2.

Badawy RA, Harvey AS, Macdonell RA.

J Clin Neurosci. 2009 Apr;16(4):485-500. doi: 10.1016/j.jocn.2008.10.001. Epub 2009 Feb 20. Review.

PMID:
19230676
50.

Cortical hyperexcitability and epileptogenesis: understanding the mechanisms of epilepsy - part 1.

Badawy RA, Harvey AS, Macdonell RA.

J Clin Neurosci. 2009 Mar;16(3):355-65. doi: 10.1016/j.jocn.2008.08.026. Epub 2009 Jan 4. Review.

PMID:
19124246

Supplemental Content

Loading ...
Support Center